Advertisement
Advertisement
BWAY
Brainsway Ltd. - ADR
8.73
USDSponsored
-0.25
-2.78%
Nov 19, 15:59 UTC -5
Closed
After-Market
8.69
-0.04
-0.52%
Brainsway Ltd. - ADR (BWAY) Earnings
BWAY Earnings Reports
Positive Surprise Ratio
BWAY beat 14 of 20 last estimates.
70%
Next Report
Date of Next Report
Mar 09, 2027
Estimate for Q4 26 (Revenue/ EPS)
$56.22M
/$0.22
Implied change from Q3 26 (Revenue/ EPS)
+2.64%
/+46.67%
Implied change from Q4 25 (Revenue/ EPS)
+19.14%
/--
Brainsway Ltd. - ADR earnings per share and revenue
On Nov 10, 2026, BWAY reported earnings of 0.15 USD per share (EPS) for Q3 26, missing the estimate of 0.21 USD, resulting in a -29.11% surprise. Revenue reached 54.78 million, compared to an expected 53.76 million, with a 1.89% difference. The market reacted with a -8.33% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.22 USD, with revenue projected to reach 56.22 million USD, implying an increase of 46.67% EPS, and increase of 2.64% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
What were Brainsway Ltd. - ADR's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Brainsway Ltd. - ADR reported EPS of $0.15, missing estimates by -29.11%, and revenue of $54.78M, 1.89% above expectations.
How did the market react to Brainsway Ltd. - ADR's Q3 2026 earnings?
The stock price moved down -8.33%, changed from $11.64 before the earnings release to $10.67 the day after.
When is Brainsway Ltd. - ADR expected to report next?
The next earning report is scheduled for Mar 09, 2027.
What are the forecasts for Brainsway Ltd. - ADR's next earnings report?
Based on --
analysts, Brainsway Ltd. - ADR is expected to report EPS of $0.22 and revenue of $56.22M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.